Condition
Bladder Cancer Stage IV
Total Trials
3
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Active Not Recruiting1
Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04562311Phase 2Active Not RecruitingPrimary
Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma
NCT06170177Recruiting
Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy
NCT04598724Completed
Addressing Barriers to Palliative Care Use in Bladder Cancer
Showing all 3 trials